TABLE 2.
Cytokine | Genotype | Day 4 p.i. |
Day 6 p.i. |
||
---|---|---|---|---|---|
pg/ml (±SD) | P | pg/ml (±SD) | P | ||
IL-1α | WT | 1.3 (±1.6) | 2.6 (±2.3) | ||
Ifnar−/− | 5.3 (±8.3) | 0.93 | |||
Irf3−/− × Irf7−/− | 10.6 (±11.5) | 0.08 | 0.6 (±1.4) | 0.05 | |
Mavs−/− | 0 (±0) | 0.03 | 5.4 (±7.8) | 0.96 | |
IL-1β | WT | 189.4 (±44.2) | 208.2 (±53.4) | ||
Ifnar−/− | 266.0 (±179.8) | 0.54 | |||
Irf3−/− × Irf7−/− | 205.7 (±135.5) | 0.99 | 109.1 (±101.3) | 0.04 | |
Mavs−/− | 123.5 (±95.1) | 0.07 | 88.9 (±101.5) | 0.02 | |
IL-2 | WT | 25.0 (±14.6) | 26.9 (±21.9) | ||
Ifnar−/− | 18.9 (±11.3) | 0.55 | |||
Irf3−/− × Irf7−/− | 20.9 (±14.1) | 0.51 | 14.9 (±11.9) | 0.50 | |
Mavs−/− | 16.6 (±12.8) | 0.05 | 28.3 (±12.7) | 0.22 | |
IL-3 | WT | 12.8 (±11.9) | 16.5 (±13.3) | ||
Ifnar−/− | 5.13 (±7.19) | 0.15 | |||
Irf3−/− × Irf7−/− | 8.6 (±9.9) | 0.68 | 4.6 (±7.1) | 0.09 | |
Mavs−/− | 3.6 (±3.3) | 0.17 | 2.0 (±3.1) | 0.008 | |
IL-4 | WT | 6.9 (±8.4) | 8.6 (±9.1) | ||
Ifnar−/− | 2.5 (±3.9) | 0.30 | |||
Irf3−/− × Irf7−/− | 3.0 (±5.7) | 0.20 | 2.1 (±5.0) | 0.32 | |
Mavs−/− | 0 (±0) | 0.06 | 0 (±0) | 0.03 | |
IL-5 | WT | 14.3 (±7.5) | 16.2 (±7.1) | ||
Ifnar−/− | 10.2 (±3.1) | 0.15 | |||
Irf3−/− × Irf7−/− | 6.2 (±4.2) | 0.004 | 9.2 (±10.2) | 0.17 | |
Mavs−/− | 8.8 (±5.8) | 0.15 | 3.5 (±5.8) | 0.002 | |
IL-6 | WT | 4.2 (±1.5) | 5.9 (±2.9) | ||
Ifnar−/− | 1,048 (±1,921) | 0.00008 | |||
Irf3−/− × Irf7−/− | 606 (±1,055) | <0.0001 | 56.8 (±107.4) | 0.76 | |
Mavs−/− | 5.8 (±4.8) | 0.64 | 146.1 (±279.1) | 0.0002 | |
IL-9 | WT | 108.6 (±115.4) | 116.5 (±131.9) | ||
Ifnar−/− | 337.9 (±410.3) | 0.36 | |||
Irf3−/− × Irf7−/− | 159.7 (±282.9) | 0.68 | 0 (±0) | 0.03 | |
Mavs−/− | 96.3 (±167.6) | 0.64 | 325.6 (±425.8) | 0.45 | |
IL-10 | WT | 22.8 (±16.3) | 25.6 (±14.1) | ||
Ifnar−/− | 23.8 (±14.6) | 0.75 | |||
Irf3−/− × Irf7−/− | 31.6 (±35.1) | 0.63 | 10.9 (±6.9) | 0.01 | |
Mavs−/− | 17.4 (±17.0) | 0.31 | 16.7 (±15.0) | 0.18 | |
IL-12 (p40) | WT | 42.8 (±30.9) | 35.4 (±17.6) | ||
Ifnar−/− | 341.7 (±164.1) | <0.0001 | |||
Irf3−/− × Irf7−/− | 338.7 (±248.8) | <0.0001 | 32.6 (±25.1) | 0.58 | |
Mavs−/− | 86.5 (±79.2) | 0.09 | 69.7 (±77.6) | 0.35 | |
IL-12 (p70) | WT | 18.6 (±12.2) | 21.3 (±8.7) | ||
Ifnar−/− | 74.5 (±93.6) | 0.51 | |||
Irf3−/− × Irf7−/− | 33.8 (±31.2) | 0.81 | 13.3 (±11.9) | 0.11 | |
Mavs−/− | 14.6 (±11.6) | 0.55 | 21.8 (±29.0) | 0.17 | |
IL-13 | WT | 31.6 (±26.3) | 47.6 (±52.2) | ||
Ifnar−/− | 30.3 (±31.9) | 0.97 | |||
Irf3−/− × Irf7−/− | 47.2 (±61.9) | 0.72 | 10.19 (±15.0) | 0.04 | |
Mavs−/− | 14.0 (±25.4) | 0.052 | 12.3 (±13.3) | 0.03 | |
IL-17 | WT | 7.7 (±5.1) | 8.7 (±6.6) | ||
Ifnar−/− | 5.3 (±5.9) | 0.15 | |||
Irf3−/− × Irf7−/− | 5.0 (±4.7) | 0.12 | 5.1 (±4.3) | 0.28 | |
Mavs−/− | 2.5 (±2.1) | 0.02 | 2.4 (±1.6) | 0.07 | |
Eotaxin | WT | 422.5 (±287.0) | 478.5 (±230.7) | ||
Ifnar−/− | 451.5 (±462.0) | 0.84 | |||
Irf3−/− × Irf7−/− | 344.2 (±292.9) | 0.42 | 178.5 (±170.8) | 0.005 | |
Mavs−/− | 145.1 (±189.2) | 0.03 | 180.2 (±206.0) | 0.01 | |
G-CSF | WT | 15.8 (±5.2) | 13.6 (±5.5) | ||
Ifnar−/− | 3,064 (±4,307) | 0.0004 | |||
Irf3−/− × Irf7−/− | 3,000 (±3,767) | <0.0001 | 106.7 (±146.5) | 0.09 | |
Mavs−/− | 10.8 (±8.2) | 0.15 | 1,307 (±2,543) | 0.03 | |
GM-CSF | WT | 70.8 (±26.6) | 74.8 (±29.3) | ||
Ifnar−/− | 86.5 (±32.8) | 0.12 | |||
Irf3−/− × Irf7−/− | 63.5 (±23.9) | 0.43 | 57.6 (±39.7) | 0.23 | |
Mavs−/− | 43.9 (±19.1) | 0.06 | 22.0 (±28.3) | 0.03 | |
IFN-γ | WT | 2.5 (±2.1) | 2.8 (±1.4) | ||
Ifnar−/− | 34.2 (±22.8) | 0.0004 | |||
Irf3−/− × Irf7−/− | 4.9 (±3.9) | 0.11 | 3.9 (±3.7) | 0.94 | |
Mavs−/− | 1.5 (±1.5) | 0.29 | 6.4 (±5.1) | 0.10 | |
KC | WT | 28.7 (±9.5) | 35.3 (±18.7) | ||
Ifnar−/− | 384.2 (212.1) | 0.0008 | |||
Irf3−/− × Irf7−/− | 285.5 (196.0) | <0.0001 | 28.5 (±24.6) | 0.23 | |
Mavs−/− | 61.6 (±59.9) | 0.79 | 87.6 (±48.8) | 0.008 | |
MCP-1 | WT | 156.1 (±113.0) | 202.0 (±132.8) | ||
Ifnar−/− | 716.6 (±267.5) | 0.0003 | |||
Irf3−/− × Irf7−/− | 902.8 (±786.5) | 0.0026 | 195.2 (±221.3) | 0.39 | |
Mavs−/− | 335.5 (±435.0) | 0.98 | 946.6 (±903.8) | 0.0043 | |
MIP-1α | WT | 1.6 (±1.5) | 2.1 (±1.9) | ||
Ifnar−/− | 8.8 (±6.6) | 0.004 | |||
Irf3−/− × Irf7−/− | 5.8 (±3.6) | 0.0001 | 5.6 (±5.1) | 0.13 | |
Mavs−/− | 2.7 (±5.2) | 0.52 | 6.6 (±6.8) | 0.12 | |
MIP-1β | WT | 36.6 (±22.8) | 45.2 (±20.4) | ||
Ifnar−/− | 35.0 (±24.0) | 0.91 | |||
Irf3−/− × Irf7−/− | 23.7 (±12.3) | 0.21 | 38.8 (±36.6) | 0.71 | |
Mavs−/− | 31.5 (±16.2) | 0.69 | 18.5 (±16.9) | 0.03 | |
RANTES | WT | 14.5 (±5.8) | 14.1 (±5.1) | ||
Ifnar−/− | 85.6 (±52.3) | 0.0008 | |||
Irf3−/− × Irf7−/− | 50.9 (±34.5) | 0.0001 | 12.6 (±7.6) | 0.64 | |
Mavs−/− | 15.3 (±17.1) | 0.30 | 31.6 (±19.8) | 0.04 | |
TNF-α | WT | 276.4 (±193.8) | 334.2 (±182.7) | ||
Ifnar−/− | 198.4 (±117.9) | 0.36 | |||
Irf3−/− × Irf7−/− | 179.1 (±113.4) | 0.20 | 145.2 (±101.3) | 0.05 | |
Mavs−/− | 155.0 (±157.2) | 0.17 | 137.3 (±114.5) | 0.04 |
The indicated strains of mice were infected with OROV. Serum was collected on days 4 and 6 postinfection (p.i.), and cytokines and chemokines were measured by Bio-Plex array. Data represent the means (±SD) in pg/ml from 8 to 12 mice per group. Statistical significance was determined using the Mann-Whitney test, and P values were obtained after comparison to infected WT mice.